Figure 2.
Bridging information, including exposure–response relationships, from the original patient population studied in clinical trials to specific populations that will receive the drug in real‐world clinical practice.
Bridging information, including exposure–response relationships, from the original patient population studied in clinical trials to specific populations that will receive the drug in real‐world clinical practice.